On the stock market since 2022, it operates in the world of technology. It has 45 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
Revenue is spread across several lines; no single product carries the company.
Average growth of 11% a year over the last 4 years. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Revenue Growth: Sales are growing slowly.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Sales run at $36.3M a year. A small number, but proof the product has real buyers.
It pays out $3.25 per share each year — regular cash for whoever holds the stock.
A loss of $8.9M against $36.3M in annual sales. And on top of that, sales fell from the year before.
At the current pace of spending, the cash lasts about 1.1 years. After that, the company needs to find new money.
On our five-subject report card, INVUP sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: INVUP is a high-risk stock — not yet profitable, and its future rides on its product catching on.